Medtronic’s MIS Drill Received FDA Approval Ahead Of Schedule

No comments

Medtronic has announced that the U.S. Food and Drug Administration (FDA) has cleared the use of navigated interbody high-speed drills with the Robotic Guidance System. Even in the midst of the COVID19 pandemic the company has received the clearance earlier than anticipated. This system now integrates the surgical planning software with robotic guidance. Spinal instruments are used to stabilize the spine and help the surgeon carry out the procedure during minimally invasive spinal (MIS) procedures. 

With this new system, surgeons can create a detailed plan for MIS procedures using the patients preop. CT scans. They can select the region of interest,  the specific vertebrae, and then plan each implant. They can also add and optimize the placement to the ideal size and trajectory with ease. According to Medtronic, the high-speed drills enable improved trajectory precision, from the initial pilot hole creation to the attachments, and dissecting tools. They are now able to provide accurate drilling with speeds up to 75,000 rpm.

Medtronics presence in the MIS Surgery Market

Medtronic is active in both the surgical instrumentation and MIS product markets as the Top Spinal Implants Manufacturers in the United States. The company sells the Midas Rex® line of instrumentation for use in spinal procedures. This brand includes products, such as Medtronic’s Midas Rex® high-speed surgical drills and nucleus removal tools. One such tool is the Spine Shaver Nucleus Removal Set. Like most spinal and orthopedic companies, Medtronic also sells general surgical instrumentation that can be used in spinal procedures, such as the PEAK® Surgery System of soft-tissue dissection devices.

“Operating rooms are very complex environments, and we look forward to incorporating new functionality into our Mazor workflow to enhance the predictability and precision of a broader range of procedures leading to better patient outcomes,”

said Dr.Eiman Shafa of Twin Cities Spine Cente

Minimally Invasive Spinal Procedure Numbers

There are more procedures using minimally invasive spinal (MIS) pedicle screws than any other MIS device segment. The latest market study shows that there are over 100,000 MIS pedicle screw procedures performed every year. The number of these procedures performed will continue to grow at a mid-to-low-single-digit rate over the next few years. The second-largest procedure type was MIS interbody device placements.

MIS Surgery Market Size and Forecast

In 2019, the total U.S. MIS surgery instrumentation market was valued at over $220 million. The growth in the market is expected to keep pace with the overall transition to minimally invasive spinal procedures. Many patients prefer minimally invasive procedures  as they reduce muscle and tissue damage at the surgical site and decrease complication frequencies as well as intraoperative times. Clinical outcomes have been largely positive, further favoring the use of minimally invasive techniques over open procedures.

Register to receive a free Market Report Suite for Minimally Invasive Spinal Implants 2019-2025 synopsis

A significant limiter of the MIS fusion market is the complexity of the procedures and the skill required to master them. Older generations of doctors and surgeons may be reluctant to switch to minimally invasive surgery, as it takes a considerable investment of time to master the technique. However, innovative systems, such as Medtronics Midas Rex, could be a huge asset to the overall market. 

Via: Medtronic 

iData ResearchMedtronic’s MIS Drill Received FDA Approval Ahead Of Schedule